It was mostly a good thing when the American Society of Clinical Oncology changed its embargo rules for annual meeting abstracts in 2008. The old "embargoed but freely available" system resulted in widespread leaks. The new one makes everything available at once. But, Brian Reid writes on Embargo Watch, abruptly releasing such a large amount of information has created a new problem: Overload. "The huge number of options creates a disincentive to paw through the data."
